Skip to main content
    O

    Olema Pharmaceuticals Inc (OLMA)

    Official site

    HEALTHCARE • BIOTECHNOLOGY • NASDAQ

    $7.36
    -0.20 (-2.65%)

    Market Cap: $662.30M

    Last updated: Nov 17, 2026 at 11:06 AM ET

    Olema Pharmaceuticals Inc (OLMA) Earnings: Report Dates and Results

    Updated Nov 9, 2026. Results come from company earnings reports, and estimates are consensus analyst estimates.

    Olema Pharmaceuticals (OLMA) is expected to report earnings on Mar 15, 2027. In the quarter ended Sep 30, 2026, Olema Pharmaceuticals reported EPS of -$0.73, below the -$0.60 estimate. It beat the EPS estimate in 3 of the last 8 quarters.

    Earnings

    Performance (10Y)

    Beat Rate
    32%(8/25)
    Avg Surprise
    -21.95%

    Upcoming Estimates

    Reports Mar 15, 2027 (est.)Period ending Dec 31, 2026
    EPS Consensus-$0.72
    Range-$0.76 - -$0.55
    12 analysts
    Revenue Consensus
    N/A
    RangeN/A
    10 analysts
    Reports May 10, 2027 (est.)Period ending Mar 31, 2027
    EPS Consensus-$0.69
    Range-$0.81 - -$0.62
    4 analysts
    EPS Revisions
    0
    3
    30d
    EPS Estimate DriftChange to current
    90d ago-$0.65-5.4%
    60d ago-$0.65-5.4%
    30d ago-$0.61-12.8%
    7d ago-$0.61-12.8%
    Current-$0.69
    Revenue Consensus
    N/A
    RangeN/A
    5 analysts

    Next Report

    OLMA has an expected report date of Mar 15, 2027.

    Earnings History

    Of the 25 quarters below that had an estimate, OLMA beat 8, missed 15 and matched 2. The widest gap in the table came in the quarter ended Dec 31, 2024, when EPS landed 394.46% below the estimate.

    Quarter endedEPSEstimateRangeSurpriseResultYoYAnalystsRevisionsReported
    Sep 30, 2026-$0.73-$0.60-$0.73 - -$0.50-21.67%MissN/A91 up, 7 downNov 9, 2026
    Jun 30, 2026-$0.61-$0.53-$0.63 - -$0.49-15.09%MissN/A94 up, 4 downAug 10, 2026
    Mar 31, 2026-$0.52-$0.54-$0.59 - -$0.50+3.70%BeatN/A103 up, 2 downMay 12, 2026
    Dec 31, 2025-$0.50-$0.52-$0.65 - -$0.44+3.28%BeatN/A90 up, 1 downMar 16, 2026
    Sep 30, 2025-$0.49-$0.45-$0.58 - -$0.38-8.89%MissN/A85 up, 0 downNov 10, 2025
    Jun 30, 2025-$0.51-$0.44-$0.70 - -$0.37-15.91%MissN/A61 up, 0 downAug 11, 2025
    Mar 31, 2025-$0.36-$0.46-$0.59 - -$0.39+21.74%BeatN/A32 up, 0 downMay 13, 2025
    Dec 31, 2024-$0.51$0.17-$0.70 - $4.23-394.46%MissN/A63 up, 3 downMar 18, 2025
    Sep 30, 2024-$0.60-$0.57-$0.63 - -$0.50-5.26%MissN/A70 up, 0 downNov 12, 2024
    Jun 30, 2024-$0.54-$0.54-$0.65 - -$0.470.00%In lineN/A70 up, 0 downAug 6, 2024
    Mar 31, 2024-$0.56-$0.55-$0.58 - -$0.51-1.82%MissN/A70 up, 0 downMay 8, 2024
    Dec 31, 2023-$0.49-$0.48-$0.65 - -$0.40-2.08%MissN/A90 up, 0 downMar 11, 2024
    Sep 30, 2023-$0.48-$0.51-$0.69 - -$0.38+5.88%BeatN/A80 up, 0 downNov 7, 2023
    Jun 30, 2023-$0.49-$0.71-$0.75 - -$0.69+30.99%BeatN/A70 up, 0 downAug 8, 2023
    Mar 31, 2023-$0.70-$0.69-$0.73 - -$0.60-1.45%MissN/A60 up, 0 downMay 9, 2023
    Dec 31, 2022-$0.65-$0.65-$0.75 - -$0.590.00%In lineN/A50 up, 0 downMar 9, 2023
    Sep 30, 2022-$0.57-$0.78-$0.90 - -$0.68+26.92%BeatN/A50 up, 0 downNov 8, 2022
    Jun 30, 2022-$0.82-$0.66N/A-24.24%MissN/AN/A0 up, 0 downAug 9, 2022
    Mar 31, 2022-$0.58-$0.60-$0.64 - -$0.45+3.33%BeatN/A40 up, 0 downMay 9, 2022
    Dec 31, 2021-$0.54-$0.49-$0.65 - -$0.45-10.20%MissN/A50 up, 0 downFeb 28, 2022
    Sep 30, 2021-$0.45-$0.43-$0.51 - -$0.42-4.65%MissN/A5N/ANov 10, 2021
    Jun 30, 2021-$0.42-$0.38-$0.42 - -$0.33-10.53%MissN/A5N/AAug 10, 2021
    Mar 31, 2021-$0.39-$0.27-$0.29 - -$0.27-44.44%MissN/A4N/AMay 11, 2021
    Dec 31, 2020-$0.50-$0.18-$0.24 - -$0.10-177.78%MissN/A3N/AMar 17, 2021
    Sep 30, 2020-$0.03-$0.50N/A+94.00%BeatN/AN/AN/ANov 19, 2020
    Last 25 quarters

    Annual EPS

    EPS for the fiscal year ended Dec 31, 2025 was -$1.86, after -$2.21 the year before. It was -$0.53 for the year ended Dec 31, 2020, the oldest of the 6 fiscal years shown.

    Fiscal year endedEPSChange
    Dec 31, 2025-$1.86N/A
    Dec 31, 2024-$2.21N/A
    Dec 31, 2023-$2.16N/A
    Dec 31, 2022-$2.62N/A
    Dec 31, 2021-$1.80N/A
    Dec 31, 2020-$0.53N/A

    Frequently Asked Questions About OLMA

    When is Olema Pharmaceuticals's next earnings date?

    Olema Pharmaceuticals's next earnings report is expected for Mar 15, 2027.

    Did OLMA beat earnings estimates last quarter?

    No. Olema Pharmaceuticals reported EPS of -$0.73 for the quarter ended Sep 30, 2026, below the -$0.60 estimate by 21.67%.

    What EPS do analysts expect from OLMA next quarter?

    The consensus EPS estimate for Olema Pharmaceuticals for the quarter ending Dec 31, 2026 is -$0.72 from 12 analysts, with estimates from -$0.76 to -$0.55.

    How often does OLMA beat earnings estimates?

    Olema Pharmaceuticals beat the EPS estimate in 3 of the last 8 quarters, with an average surprise of -53.41%.